Discover 1,426 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,426
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
for
CLL/SLL
Location: Canton OH, Cleveland OH, Charlotte NC, Boston MA,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04215809
Phase1, Recruiting
Active & Responsive
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Location: Canton OH, Pittsburgh PA, Cincinnati OH, Toronto,
Sponsor: Ascendis Pharma Oncology Division A/S
Sex: All
Age: 18+
Code: NCT05081609
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: Middleburg Heights OH, Saint Clair Shores MI, Ann Arbor MI,
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Active & Responsive
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Cleveland OH, Pittsburgh PA, Indianapolis IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation